Guifang Ouyang

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyBiologically active moleculesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
A Mitochondria-Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation.

|Jun 10, 2026
CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT.

|Mar 02, 2026
Whole transcriptome sequencing reveals differences in the pathogenesis of myelodysplastic syndromes and acute myeloid leukemia.

Miao Zhou, Tongyu Li, Yun Li

|Mar 01, 2026
A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma.

Tongyu Li, Wanchuan Zhuang, Shufang Fan

|Jul 23, 2025
Impact of Decitabine Conditioning on Allo-HSCT Outcomes in AML and Intermediate-to-High-Risk MDS Patients in Remission.

Shuling Yu, Wanchuan Zhuang, Shengfa Gao

|Mar 27, 2024
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.

Miao Zhou, Tongyu Li, Ping Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Ping Zhang

1 joint publications

Xiaosu Zhou

1 joint publications

Qitian Mu

1 joint publications

Hongwei Chen